December 05, 2024, Inside Medical Liability Online
Incidental Findings Can Lead to Malpractice Claims: Practice Protocols Can Help
If the ordering practitioner does not follow up, an incidental finding may lead to patient harm and result in a malpractice claim. The Doctors Company has completed a new analysis of medical malpractice claims against our members in which an incidental finding was identified as a contributing factor.
Search
Fitch Ratings Affirms ‘A’ Ratings, ‘Stable’ Outlook for The Doctors Company
June 30, 2025: Fitch Ratings has affirmed its “A” (Strong) Insurer Financial Strength ratings for The Doctors Company, the nation’s largest physician-owned medical malpractice insurer and part of TDC Group. The outlook of these ratings is “Stable.”
Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
Psychiatry Resources
Get risk management/patient safety resources and free accredited education opportunities for clinicians providing psychiatry care.
December 15, 2023, Inside Medical Liability
MPL Cases: What Are the Primary Drivers of High-Indemnity Medical Malpractice Claims?
Jacqueline Ross, RN, PhD, Coding Director, and Kathrine Soulsby, RN, BSN, Senior Patient Safety Analyst, The Doctors Company, part of TDC Group, investigate high-dollar medical malpractice litigation and explain how reducing diagnostic errors is paramount to enhancing patient safety and mitigating loss costs.
Professional Education
Anesthesia: Diagnosis and Management of Posterior Anterior Neck Hematoma
Anterior neck hematoma (ANH) is a serious emergency that can block the airway and endanger the life of a patient who has had neck surgery. Anesthesia professionals need to be ready to identify ANH and act when there is no surgeon nearby. This course covers recognizing the signs and symptoms of postoperative ANH and strategies for response.
Set Expectations for New Patients With a Conditions of Treatment Agreement
Consider developing a plan to preemptively manage challenging patient behaviors when they are first identified.
The Doctors Company Receives Datos Insights 2025 Impact Award for Insurance Innovation
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, part of TDC Group, announced today that it has received a 2025 Datos Insights Impact Award for Insurance Innovation. The awards program recognizes organizations that demonstrate excellence in implementing innovative technology solutions that drive measurable business results and industry leadership.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
The Doctors Company Assists Members Impacted by Hurricane Helene
Due to disruption to member medical practices from Hurricane Helene and consistent with direction from state insurance regulation offices, The Doctors Company will adjust policy cancellation and premium installment due dates for affected members. Premium due dates have generally been extended in Florida, Georgia, North Carolina, South Carolina, and Tennessee, with Florida extending from September 26, 2024, to November 26, 2024.
